What Grupo Serbitec does

Grupo Serbitec is a Mexican private healthcare services company founded in 2002 that delivers integrated, non-hospital medical care to patients in their homes across six major metropolitan areas: Mexico City, Estado de México, Puebla, Guadalajara, Monterrey, and Tlaxcala. Its core offering is Home Care, which bundles professional nursing, physical therapy, respiratory therapy, occupational therapy, speech and swallowing therapy, geriatric care, mobile diagnostics (clinical analysis and X-rays), ambulance/transport, and medical equipment provision (including oxygen therapy and patient monitoring). The company highlights a 35% cost advantage versus equivalent hospital-based care and a 48-hour nationwide service response window. With 200+ healthcare professionals, Grupo Serbitec coordinates care plans with both public insurers (IMSS, ISSSTE) and private aseguradoras and also serves direct-pay patients acquired primarily through WhatsApp messaging and a centralized contact center.

The company's underlying technical and operational platform rests on three differentiated components: an ISO 9001:2015-certified Central de Mezclas (compounding facility) for sterile IV mixture preparation including oncology therapies and parenteral nutrition, operating under COFEPRIS sanitary license; a national cold-chain pharmaceutical distribution network (red de distribución nivel República); and a newly launched Consultorio para Infusión (Infusion Clinic) opened in 2024 that provides outpatient oncology infusion and parenteral nutrition under medical supervision. These components are complemented by a pharmacovigilance service that reports adverse drug reactions to Mexican health authorities.

Commercially, Grupo Serbitec generates revenue through four primary streams: professional home care services (nursing, therapy, monitoring) billed via direct patient payments and insurance reimbursements; managed compounding services at Central de Mezclas supplying IV mixtures to pharmaceutical industry players, authorized wholesalers, and clinical study sponsors; pharmaceutical and medical supply distribution through pharmacy point-of-sale and the national cold-chain network; and, most recently, fee-for-service oncology infusion and parenteral nutrition at the Consultorio para Infusión. GTM is sales-led and direct-to-consumer, executed via WhatsApp and phone contact with families, combined with B2B relationship development with public and private insurers. No public pricing or contract terms are disclosed.

Name

Grupo Serbitec

Legal name

Grupo Serbitec

Website

https://serbitec.com

Company type

Private

Founded year

2002

Operating status

Operating

Headcount range

101–250 employees

Short description

Grupo Serbitec is a Mexican home healthcare provider founded in 2002 that delivers nursing, physical therapy, rehabilitation, and infusion services to patients across six major Mexican metros. It operates an ISO 9001:2015-certified IV compounding center and serves insured and direct-pay patients.

Ownership category

akta.pro rank

Product category

Home Healthcare Services

NAICS

Medical and Diagnostic Laboratories (62151), Ambulatory Health Care Services (621), Medical Laboratories (621511)

SIC

Services-Medical Laboratories (8071), Services-Specialty Outpatient Facilities, Nec (8093), Services-Testing Laboratories (8734)

akta.pro primary industry

Transitional Care Units (TCU) (HLAFAFAF)

akta.pro secondary industry

Central Laboratory Services (Core Lab Operations) (HLAGAEAA)

Keywords

• Home healthcare services
• Home nursing care
• IV compounding pharmacy
• Infusion therapy services
• Mobile diagnostic services

Headquarters

HQ city

Cuauhtémoc

HQ country

Mexico

HQ region

Latin America

Offices2 records

Markets served

GTM type

B2B and B2C

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Marketing or Sales, Technology or R&D, Supply Chain

Revenue model

1. Home Care Services: Comprehensive home medical care services including professional nursing, physical therapy, respiratory therapy, occupational therapy, speech therapy, swallowing therapy, and patient monitoring. Revenue generated through direct patient payments and insurance reimbursements.
2. Central de Mezclas - IV Mixtures: Preparation and distribution of intravenous mixtures including oncology therapies and parenteral nutrition. Supplies pharmaceutical industry and authorized wholesalers, also participates in clinical studies for drug development.
3. Pharmaceutical Distribution: Distribution of medications and medical supplies through pharmacy point of sale and national distribution network.
4. Infusion Clinic Services: Oncology infusion and parenteral nutrition services at dedicated infusion clinic facility, with specialized medical supervision and complementary nutrition and psychological support services.

Pricing tiers

Go-to-market motion2 records

Distribution channels3 records

Marketing channels3 records

Core offering

Grupo Serbitec is a Mexico-based home healthcare services provider delivering comprehensive non-hospital medical care, including professional nursing, physical and respiratory therapy, mobile diagnostics, and medical equipment at patient homes. The company also operates an ISO 9001:2015-certified Central de Mezclas (compounding center) for sterile IV mixture preparation, an outpatient Consultorio para Infusión (infusion clinic), and a national pharmaceutical distribution network with cold-chain capabilities. Services are offered to private patients and to patients covered by public and private insurance companies across Mexico.

Product overview

Grupo Serbitec operates as a unified home healthcare platform offering integrated medical services outside hospital settings. The portfolio centers on Home Care as the core offering, complemented by specialized services including Central de Mezclas (ISO-certified compounding pharmacy for IV mixtures), Consultorio para Infusión (outpatient infusion clinic), and Nutrition Parenteral services. Supporting services include home nursing, physical therapy, respiratory therapy, mobile diagnostics, oxygen therapy, and pharmacovigilance. The company serves over 200 patients with more than 200 professionals across Mexico.

Differentiator

Problem solved

Functional benefit

Quantifiable outcome

• Up to 35% cost savings compared to equivalent hospital-based care
• +2 more outcomes

Named customers1 record

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Two partnerships are on record, tiered core.

• COFEPRIS (Comisión Federal para la Protección contra Riesgos Sanitarios)coreOthersRegulatory partnership for pharmaceutical and medical services licensing. COFEPRIS is the Mexican Federal Commission for Protection against Sanitary Risks that provides operating licenses for Central de Mezclas and oversees compliance with health regulations. Serbitec maintains strict adherence to sanitary license requirements.
• Public and Private Insurance Companies (Aseguradoras)coreStrategic or Co-development PartnerPartnerships with public insurance institutions (IMSS, ISSSTE, etc.) and private insurance companies to provide covered home care services to insured patients. Serbitec develops care plans in coordination with insurance company medical teams.

Scale indicators5 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Neolpharma: Mexican pharmaceutical group with hospital and specialty products including sterile injectables and parenteral nutrition. Comparable to Serbitec's Central de Mezclas on the IV/parenteral nutrition side and to the broader pharma distribution business.
• Vitalmex: Mexican provider of integrated medical solutions including home infusion, parenteral nutrition, and hospital therapies. Most directly comparable to Serbitec's home nursing, IV compounding, and infusion clinic services within Mexico.
• Fresenius Kabi México: Global leader in parenteral nutrition, IV drugs, and infusion technology with significant Mexico operations. Comparable to Serbitec's Central de Mezclas and parenteral nutrition service line as a multinational B2B IV/PN competitor.
• Pisa Farmacéutica: One of Mexico's largest pharmaceutical manufacturers with a strong IV solutions and injectables portfolio. Comparable to Serbitec's Central de Mezclas as a domestic competitor in IV therapy supply, though operating at much larger scale on the manufacturing side.

Broad incumbents

• Baxter México: Global manufacturer of IV solutions, infusion pumps, and renal/home therapies with established Mexico operations. Comparable to Serbitec's IV and parenteral nutrition offering but also operates hospital and renal product lines at much greater scale.
• Christus Muguerza: One of Mexico's largest private hospital networks, increasingly expanding outpatient and home-based services. Comparable to Serbitec as a Mexican healthcare provider with growing post-acute/home care ambitions and direct insurer relationships.
• Grupo Ángeles: Major Mexican private hospital group operating across multiple cities where Serbitec is also active. Comparable as a competing Mexican healthcare provider with the scale and brand to enter or expand into home health and post-acute services.
• B. Braun México: Global medical devices and pharmaceutical solutions company with strong presence in IV therapy, infusion systems, and clinical nutrition in Mexico. Overlaps with Serbitec's IV compounding and home infusion services but as part of a much broader hospital-focused portfolio.

Regional players

• Amedisys: US public home health and hospice operator with national coverage and strong payer relationships. Comparable to Serbitec in operating model — nursing, therapy, and post-acute home services — though serving a different geography with Medicare-led reimbursement.
• Bayada Home Health Care: One of the largest US private home health providers offering nursing, therapy, and home-based care across adult and pediatric segments. Comparable as a scaled, multi-service home care platform but operating in the US market with different payer dynamics than Serbitec's Mexico footprint.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Grupo Serbitec